在肺癌筛查中提供戒烟支持以降低肺癌死亡率:大西洋两岸错失的机会与经验教训
多国已发布高危老年人肺癌筛查(LCS)指南,但普遍推荐而未明确如何提供戒烟支持(SCS)。在LCS中提供SCS即便戒烟率不高也可显著降低肺癌死亡率,且具成本效益;作者基于英国、加拿大和美国的经验提出卫生系统应优先考虑的事项。
要点
- LCS指南推荐但未明确SCS的具体提供方式,导致错失降低烟草与肺癌相关差异的机会。
- 临床试验与建模研究显示,LCS中提供SCS即便戒烟率不高也可显著降低肺癌死亡率。
- SCS具成本效益并可节省卫生系统费用;作者基于英美加经验提出卫生系统优先事项。
核心结论
- 作者认为维持SCS作为LCS标准组成部分所需的系统与政策变革,对将疾病预防与早期发现相结合、最大化LCS全球死亡率获益至关重要。
研究设计与样本
- 本文为基于英国、加拿大和美国证据与经验的政策论述,提出卫生系统在LCS中开发或扩展SCS项目时应考虑的优先事项。
主要发现
- 临床试验与建模研究的有力证据显示,即便戒烟率不高,LCS中提供的SCS也可显著降低肺癌死亡率。
- 在较大年龄戒烟可降低肺癌风险并增加预期寿命。
- SCS干预具成本效益,并可为卫生系统带来显著费用节省。
关键数值与推荐
- 多国(主要在欧洲、北美和澳大利亚)已发布高危老年人LCS实施的国家指南,通常推荐但未明确SCS应如何提供。
临床怎么用
- 作者提出卫生系统在LCS中开发或扩展SCS项目时应考虑的一组优先事项。
- 作者认为维持SCS作为LCS标准组成部分所需的系统与政策变革至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
National guidelines for the implementation of lung cancer screening (LCS) for high-risk older adults have been issued by several countries, largely in Europe, North America, and Australia. Typically, these guidelines recommend but do not specify how smoking cessation support (SCS) should be provided to patients undergoing LCS who currently smoke. As LCS implementation progresses, delivering screening to the millions of eligible individuals around the world, the lack of best practice guidelines for SCS in the LCS setting is resulting in a growing missed opportunity to reduce persistent tobacco and lung cancer-related disparities in incidence and mortality. Quitting smoking at older ages reduces lung cancer risk and increases life expectancy. Compelling evidence from clinical trials and modeling studies has shown that, even with modest cessation rates, SCS delivered in the LCS setting can considerably reduce lung cancer mortality, with the potential to reduce global, racial, economic, and geographic disparities in lung cancer. Moreover, SCS interventions are cost-effective and can lead to significant cost savings for the health system. On the basis of the evidence and lessons learned in the United Kingdom, Canada, and the United States, we propose a set of priorities for health systems to consider when developing or expanding SCS programs in the LCS setting. We argue that the system and policy changes needed to maintain SCS as a standard component of LCS are essential to capitalize on this important opportunity to integrate disease prevention with early detection, thereby maximizing the mortality benefit of LCS worldwide.
引用
- Taylor KL, Williams RM, Meza R, et al. Reducing Lung Cancer Mortality by Providing Smoking Cessation Support in the Lung Cancer Screening Setting: Missed Opportunities and Lessons Learned on Both Sides of the Atlantic. J Thorac Oncol. 2025. PMID: 40617668. doi:10.1016/j.jtho.2025.03.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。